The synthesis of iodine-123 labelled mono- and di-iodo derivatives of hypericin, an hydroxylated phenanthroperylenequinone which is used for photodynamic therapy and has been shown to accumulate in several tumour types, is reported. Labelling was performed by electrophilic substitution on hypericin or iodohypericin with [123I]iodide in the presence of peracetic acid and provided both mono-[123I]iodohypericin and di-[123I]iodohypericin in good radiochemical yields (>80%). Mono-[123I]iodohypericin was obtained with a high specific activity (925 GBq/μmol) whereas di-[123I]iodohypericin was obtained in low specific activity (4 GBq/μmol) due to deiodination and subsequent iodination of iodohypericin which occurred during the labelling reaction. Biodistribution studies in mice showed a slow blood clearance and extensive hepatobiliary clearance as well as faecal excretion for both compounds. They will be further evaluated with regard to their tumor seeking properties. Copyright © 2004 John Wiley & Sons, Ltd.
报告了
碘-123标记的单
碘和二
碘金丝桃素衍
生物的合成,
金丝桃素是一种羟基化
菲呫醌,用于光动力疗法,并已证明可积聚在多种肿瘤中。标记是通过在
过乙酸存在下,用[123I]
碘化物对
金丝桃素或
碘化金丝桃素进行亲电取代反应而进行的,并提供了单[123I]
碘化金丝桃素和二[123I]
碘化金丝桃素,放射
化学收率良好(>80%)。单[123I]
碘化金丝桃素具有高比活度(925 GBq/μmol),而二[123I]
碘化金丝桃素的比活度较低(4 GBq/μmol),这是由于在标记反应期间发生了
碘化金丝桃素的脱
碘和随后的
碘化反应。在小鼠体内的
生物分布研究表明,这两种化合物具有缓慢的血液清除和广泛的肝胆清除以及粪便排泄。将进一步评估它们寻找肿瘤的特性。版权 © 2004 John Wiley & Sons, Ltd.